Is XENE stock safe? | Glauxie AI

Q: Is XENE stock safe?

Xenon Pharmaceuticals Inc. (XENE) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Andrea DiFabio. Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline... Employees: 10,000.

Q: What are the risks of investing in XENE?

Identify key risks of investing in XENE — debt, competition, volatility, and sector headwinds.

Q: Is XENE a good long-term investment?

Evaluate XENE as a long-term investment using fundamental scores, growth metrics, and risk assessment.

Q: How much debt does XENE have?

Review XENE total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Is XENE stock safe?

🦉

Xenon Pharmaceuticals Inc. (XENE)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOAndrea DiFabio

Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment...

Key Executives

Name	Title
Andrea DiFabio	Chief Legal Officer & Corporate Secretary
Christopher John Kenney	Chief Medical Officer
Colleen Alabiso	Senior Vice President of Corporate Affairs
Darren S. Cline	Chief Commercial Officer
Gilbert	Senior Director
Ian C. Mortimer	President, Chief Executive Officer & Director

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

XENE Profile Financials

What are the risks of investing in XENE? Is XENE a good long-term investment? How much debt does XENE have?